Drug Delivery Devices Contract Manufacturing Market Size and Forecast 2021 - 2034, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Device Type, Service Type, and Geography

Description

List of Tables

According to our new research study on "Drug Delivery Devices Contract Manufacturing Market Forecast to 2031 -Global Analysis - by Device Type, Service Type, and Geography," the market is anticipated to grow from US$ 8.24 billion in 2025 to US$ 21.72 billion by 2034, with a CAGR of 11.5% during 2026-2034. The drug delivery devices contract manufacturing market growth is attributed to the increasing prevalence of chronic diseases, technological advancements and innovation, and cost efficiencies through outsourcing.

Outsourcing the design, development and production of drug delivery devices to Contract Development and Manufacturing Organizations (CDMOs) that specialize in these areas means that pharmaceutical and biotechnology companies can concentrate on their core competencies of drug development, research and development and commercialization while benefiting from the experience, expertise, technological capabilities and scale provided by third party manufacturers who manage complete end-to-end production processes. These include fabrication of components, assembly, quality assurance, testing, regulatory compliance, and packaging. Adoption of AI and digital technologies in manufacturing, emphasis on sustainable and eco-friendly manufacturing practices, and the rise of personalized and patient-centric delivery systems are expected to emerge as major drug delivery devices contract manufacturing market trends in the coming years.

The drug delivery devices contract manufacturing market in North America is segmented into the US, Canada, and Mexico. The North America drug delivery devices contract manufacturing market is expanding as the region hosts numerous facilities, with the US alone featuring over 400 specialized sites focused on class II and III devices, emphasizing precision engineering and regulatory compliance. The US holds the largest market share, followed by Canada.

In the United States alone, there are more than 400 specialized facilities that specialize in producing class II and class III medical devices with a focus on engineering precision, regulatory compliance, and developing new technologies for injectables, inhalers and transdermal delivery systems. Leading companies such as Catalent operate multiple facilities for assembling autoinjectors and pen injectors. Integer Holdings Corporation provides the assembly for infusion pumps, allowing them to quickly ramp up production to meet the needs of customers who require high volumes. According to recently released data from the Centers for Disease Control and Prevention (CDC), outsourcing of cardiovascular and orthopaedic delivery devices is projected to grow at an annualized rate of 11.4% until 2020, primarily due to increased rates of diabetes amongst adult Americans (34+ million). The total number of people working in medical device manufacturing exceeds 1 million; improvements in automation have led to a reduction of the defect rate by 20%.

Disruption in the Supply Chain resulted in a 15 % Impact to Time to Market caused by methods employed by the Case for Quality (CfQ) initiative through the FDA - Case for Quality is focused on improving quality practices and building partnerships. The Merger between Kindeva Drug Delivery and Meridian Medical Technologies and their merger in 2025 reflects the increased capacity to create parenteral and inhalation products. Conversely, Regeneron continues to expand its business activities based on Gene Therapy Vector development and Continuous Glucose Monitor (CGM) development initiatives. Additionally, our relationships with Apiject allow us to scale our Blow-Fill-Seal units at our Brookhaven facilities while simultaneously growing our line of sterile dosage forms and HCP CCC's. Our Sector has many attributes, including Skilled Workforce, Research & Development Incentives and over 50% of our Facilities utilize Renewable Energy Sources, which results in reducing our carbon footprint by 30%. Subtitle Technologies, along with Strategic Investments, create a unique environment for Advanced Drug Delivery Outsourcing. Therefore, the United States is well-positioned to be a Global Leader in Advanced Drug Delivery Outsourcing due to its advanced Technology and Strategic Investments.

The US Food and Drug Administration, World Bank Data, National Health Service (NHS), FDA (Food and Drug Administration), EMA (European Medicines Agency), and WHO (World Health Organization) are among the primary and secondary sources referred to while preparing the drug delivery devices contract manufacturing market report.

Product Code: TIPRE00042228

1. Executive Summary

1.1 Analyst Market Outlook
1.2 Market Attractiveness

2. Drug Delivery Devices Contract Manufacturing Market Landscape

2.1 Overview
2.2 Value Chain Analysis
- 2.2.1 Raw Material Suppliers / Components
- 2.2.2 Manufacturers/ Process / Technology
- 2.2.3 Distribution Landscape
- 2.2.4 End User
2.3 Supply Chain Analysis
- 2.3.1 List of Manufacturers/Suppliers
- 2.3.2 List of Potential Customers (Upto 50)
2.4 Porter's Five Force Analysis
2.5 PEST Analysis
2.6 Impact of Artificial Intelligence (AI)
2.7 Product or Technology Roadmap
2.8 Sustainability and ESG Trends
- 2.8.1 Environmental Trends
- 2.8.2 Social Trends
- 2.8.3 Governance Trends
2.9 Regulatory Framework

3. Competitive Landscape

3.1 Company Benchmarking by Key Players
3.2 Market Concentration

4. Drug Delivery Devices Contract Manufacturing Market - Key Industry Dynamics

4.1 Market Drivers
- 4.1.1 Increasing Prevalence of Chronic Diseases
- 4.1.2 Technological Advancements and Innovation
- 4.1.3 Cost Efficiencies Through Outsourcing
4.2 Market Restraints
- 4.2.1 Stringent Regulatory Requirements
- 4.2.2 Supply Chain Vulnerabilities
- 4.2.3 Quality Assurance and Manufacturing Complexities
4.3 Market Opportunities
- 4.3.1 Expansion into Emerging Markets
- 4.3.2 Integration of AI and IoT
- 4.3.3 Adoption of Sustainable Manufacturing Practices
4.4 Future Trends
- 4.4.1 Adoption of AI and Digital Technologies in Manufacturing
- 4.4.2 Emphasis on Sustainable and Eco-Friendly Manufacturing Practices
- 4.4.3 Rise of Personalized and Patient-Centric Delivery Systems
4.5 Impact of Drivers and Restraints

5. Drug Delivery Devices Contract Manufacturing Market - Global Market Analysis

5.1 Drug Delivery Devices Contract Manufacturing Market Revenue (US$ Million), 2021-2034
5.2 Drug Delivery Devices Contract Manufacturing Market Forecast and Analysis

6. Drug Delivery Devices Contract Manufacturing Market Revenue Analysis -Service Type

6.1 Drug Delivery Devices Contract Manufacturing Market Forecasts and Analysis by Service Type
- 6.1.1 Full-device Manufacturing
  - 6.1.1.1 Overview
  - 6.1.1.2 Full-device Manufacturing: Drug Delivery Devices Contract Manufacturing Market -Revenue, 2021-2034 (US$ Million)
- 6.1.2 Sub-assembly and Components
  - 6.1.2.1 Overview
  - 6.1.2.2 Sub-assembly and Components: Drug Delivery Devices Contract Manufacturing Market -Revenue, 2021-2034 (US$ Million)
- 6.1.3 Materials-specific Services
  - 6.1.3.1 Overview
  - 6.1.3.2 Materials-specific Services: Drug Delivery Devices Contract Manufacturing Market -Revenue, 2021-2034 (US$ Million)

7. Drug Delivery Devices Contract Manufacturing Market Revenue Analysis -Device Type

7.1 Drug Delivery Devices Contract Manufacturing Market Forecasts and Analysis by Device Type
- 7.1.1 Infusion Devices and Administration Set
  - 7.1.1.1 Overview
  - 7.1.1.2 Infusion Devices and Administration Set: Drug Delivery Devices Contract Manufacturing Market -Revenue, 2021-2034 (US$ Million)
- 7.1.2 Syringes
  - 7.1.2.1 Overview
  - 7.1.2.2 Syringes: Drug Delivery Devices Contract Manufacturing Market -Revenue, 2021-2034 (US$ Million)
- 7.1.3 Inhalers
  - 7.1.3.1 Overview
  - 7.1.3.2 Inhalers: Drug Delivery Devices Contract Manufacturing Market -Revenue, 2021-2034 (US$ Million)
- 7.1.4 Autoinjectors and Pen Injectors
  - 7.1.4.1 Overview
  - 7.1.4.2 Autoinjectors and Pen Injectors: Drug Delivery Devices Contract Manufacturing Market -Revenue, 2021-2034 (US$ Million)

8. Drug Delivery Devices Contract Manufacturing Market - Geographical Analysis

8.1 North America
- 8.1.1 North America Drug Delivery Devices Contract Manufacturing Market Overview
- 8.1.2 North America: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.1.3 North America: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
  - 8.1.3.1 Service Type
  - 8.1.3.2 Device Type
- 8.1.4 North America: Drug Delivery Devices Contract Manufacturing Market Breakdown by Countries
  - 8.1.4.1 United States Market
    - 8.1.4.1.1 United States: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.1.4.1.2 United States: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.1.4.1.2.1 Service Type
      - 8.1.4.1.2.2 Device Type
  - 8.1.4.2 Canada Market
    - 8.1.4.2.1 Canada: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.1.4.2.2 Canada: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.1.4.2.2.1 Service Type
      - 8.1.4.2.2.2 Device Type
  - 8.1.4.3 Mexico Market
    - 8.1.4.3.1 Mexico: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.1.4.3.2 Mexico: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.1.4.3.2.1 Service Type
      - 8.1.4.3.2.2 Device Type
8.2 Europe
- 8.2.1 Europe Drug Delivery Devices Contract Manufacturing Market Overview
- 8.2.2 Europe: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.2.3 Europe: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
  - 8.2.3.1 Service Type
  - 8.2.3.2 Device Type
- 8.2.4 Europe: Drug Delivery Devices Contract Manufacturing Market Breakdown by Countries
  - 8.2.4.1 Germany Market
    - 8.2.4.1.1 Germany: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.2.4.1.2 Germany: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.2.4.1.2.1 Service Type
      - 8.2.4.1.2.2 Device Type
  - 8.2.4.2 United Kingdom Market
    - 8.2.4.2.1 United Kingdom: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.2.4.2.2 United Kingdom: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.2.4.2.2.1 Service Type
      - 8.2.4.2.2.2 Device Type
  - 8.2.4.3 France Market
    - 8.2.4.3.1 France: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.2.4.3.2 France: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.2.4.3.2.1 Service Type
      - 8.2.4.3.2.2 Device Type
  - 8.2.4.4 Italy Market
    - 8.2.4.4.1 Italy: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.2.4.4.2 Italy: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.2.4.4.2.1 Service Type
      - 8.2.4.4.2.2 Device Type
  - 8.2.4.5 Spain Market
    - 8.2.4.5.1 Spain: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.2.4.5.2 Spain: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.2.4.5.2.1 Service Type
      - 8.2.4.5.2.2 Device Type
  - 8.2.4.6 Rest of Europe Market
    - 8.2.4.6.1 Rest of Europe: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.2.4.6.2 Rest of Europe: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.2.4.6.2.1 Service Type
      - 8.2.4.6.2.2 Device Type
8.3 Asia Pacific
- 8.3.1 Asia Pacific Drug Delivery Devices Contract Manufacturing Market Overview
- 8.3.2 Asia Pacific: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.3.3 Asia Pacific: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
  - 8.3.3.1 Service Type
  - 8.3.3.2 Device Type
- 8.3.4 Asia Pacific: Drug Delivery Devices Contract Manufacturing Market Breakdown by Countries
  - 8.3.4.1 China Market
    - 8.3.4.1.1 China: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.3.4.1.2 China: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.3.4.1.2.1 Service Type
      - 8.3.4.1.2.2 Device Type
  - 8.3.4.2 Japan Market
    - 8.3.4.2.1 Japan: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.3.4.2.2 Japan: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.3.4.2.2.1 Service Type
      - 8.3.4.2.2.2 Device Type
  - 8.3.4.3 India Market
    - 8.3.4.3.1 India: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.3.4.3.2 India: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.3.4.3.2.1 Service Type
      - 8.3.4.3.2.2 Device Type
  - 8.3.4.4 Australia Market
    - 8.3.4.4.1 Australia: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.3.4.4.2 Australia: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.3.4.4.2.1 Service Type
      - 8.3.4.4.2.2 Device Type
  - 8.3.4.5 South Korea Market
    - 8.3.4.5.1 South Korea: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.3.4.5.2 South Korea: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.3.4.5.2.1 Service Type
      - 8.3.4.5.2.2 Device Type
  - 8.3.4.6 Rest of APAC Market
    - 8.3.4.6.1 Rest of APAC: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.3.4.6.2 Rest of APAC: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.3.4.6.2.1 Service Type
      - 8.3.4.6.2.2 Device Type
8.4 Middle East and Africa
- 8.4.1 Middle East and Africa Drug Delivery Devices Contract Manufacturing Market Overview
- 8.4.2 Middle East and Africa: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.4.3 Middle East and Africa: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
  - 8.4.3.1 Service Type
  - 8.4.3.2 Device Type
- 8.4.4 Middle East and Africa: Drug Delivery Devices Contract Manufacturing Market Breakdown by Countries
  - 8.4.4.1 Saudi Arabia Market
    - 8.4.4.1.1 Saudi Arabia: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.4.4.1.2 Saudi Arabia: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.4.4.1.2.1 Service Type
      - 8.4.4.1.2.2 Device Type
  - 8.4.4.2 South Africa Market
    - 8.4.4.2.1 South Africa: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.4.4.2.2 South Africa: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.4.4.2.2.1 Service Type
      - 8.4.4.2.2.2 Device Type
  - 8.4.4.3 United Arab Emirates Market
    - 8.4.4.3.1 United Arab Emirates: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.4.4.3.2 United Arab Emirates: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.4.4.3.2.1 Service Type
      - 8.4.4.3.2.2 Device Type
  - 8.4.4.4 Rest of Middle East and Africa Market
    - 8.4.4.4.1 Rest of Middle East and Africa: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.4.4.4.2 Rest of Middle East and Africa: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.4.4.4.2.1 Service Type
      - 8.4.4.4.2.2 Device Type
8.5 South and Central America
- 8.5.1 South and Central America Drug Delivery Devices Contract Manufacturing Market Overview
- 8.5.2 South and Central America: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.5.3 South and Central America: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
  - 8.5.3.1 Service Type
  - 8.5.3.2 Device Type
- 8.5.4 South and Central America: Drug Delivery Devices Contract Manufacturing Market Breakdown by Countries
  - 8.5.4.1 Brazil Market
    - 8.5.4.1.1 Brazil: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.5.4.1.2 Brazil: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.5.4.1.2.1 Service Type
      - 8.5.4.1.2.2 Device Type
  - 8.5.4.2 Argentina Market
    - 8.5.4.2.1 Argentina: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.5.4.2.2 Argentina: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.5.4.2.2.1 Service Type
      - 8.5.4.2.2.2 Device Type
  - 8.5.4.3 Rest of South and Central America Market
    - 8.5.4.3.1 Rest of South and Central America: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.5.4.3.2 Rest of South and Central America: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.5.4.3.2.1 Service Type
      - 8.5.4.3.2.2 Device Type

9. Drug Delivery Devices Contract Manufacturing Market Industry Landscape

10. Drug Delivery Devices Contract Manufacturing Market - Key Company Profiles

10.1 MICRO
- 10.1.1 Key Facts
- 10.1.2 Business Description
- 10.1.3 Products and Services
- 10.1.4 Financial Overview
- 10.1.5 SWOT Analysis
- 10.1.6 Key Developments
10.2 Freudenberg Group
- 10.2.1 Key Facts
- 10.2.2 Business Description
- 10.2.3 Products and Services
- 10.2.4 Financial Overview
- 10.2.5 SWOT Analysis
- 10.2.6 Key Developments
10.3 Flex Ltd
- 10.3.1 Key Facts
- 10.3.2 Business Description
- 10.3.3 Products and Services
- 10.3.4 Financial Overview
- 10.3.5 SWOT Analysis
- 10.3.6 Key Developments
10.4 Jabil Inc
- 10.4.1 Key Facts
- 10.4.2 Business Description
- 10.4.3 Products and Services
- 10.4.4 Financial Overview
- 10.4.5 SWOT Analysis
- 10.4.6 Key Developments
10.5 SMC Ltd
- 10.5.1 Key Facts
- 10.5.2 Business Description
- 10.5.3 Products and Services
- 10.5.4 Financial Overview
- 10.5.5 SWOT Analysis
- 10.5.6 Key Developments
10.6 TE Connectivity Ltd
- 10.6.1 Key Facts
- 10.6.2 Business Description
- 10.6.3 Products and Services
- 10.6.4 Financial Overview
- 10.6.5 SWOT Analysis
- 10.6.6 Key Developments
10.7 Heraeus Group
- 10.7.1 Key Facts
- 10.7.2 Business Description
- 10.7.3 Products and Services
- 10.7.4 Financial Overview
- 10.7.5 SWOT Analysis
- 10.7.6 Key Developments
10.8 Cirtec Medical Corp
- 10.8.1 Key Facts
- 10.8.2 Business Description
- 10.8.3 Products and Services
- 10.8.4 Financial Overview
- 10.8.5 SWOT Analysis
- 10.8.6 Key Developments
10.9 Integer Holdings Corp
- 10.9.1 Key Facts
- 10.9.2 Business Description
- 10.9.3 Products and Services
- 10.9.4 Financial Overview
- 10.9.5 SWOT Analysis
- 10.9.6 Key Developments
10.10 Tegra Medical
- 10.10.1 Key Facts
- 10.10.2 Business Description
- 10.10.3 Products and Services
- 10.10.4 Financial Overview
- 10.10.5 SWOT Analysis
- 10.10.6 Key Developments

11. Appendix

11.1 Glossary
11.2 Research Methodology and Approach
- 11.2.1 Secondary Research
- 11.2.2 Primary Research
- 11.2.3 Market Estimation Approach
  - 11.2.3.1 Supply Side Analysis
  - 11.2.3.2 Demand Side Analysis
- 11.2.4 Research Assumptions and Limitations
- 11.2.5 Currency Conversion
11.3 About The Insight Partners
11.4 Market Intelligence Cloud